Bio Developments

(Image: Getty/Photo world)

WuXi Vaccines to build $240m facility in Ireland

By Ben Hargreaves

WuXi Biologics furthers its manufacturing presence in Ireland with a manufacturing facility for its vaccines subsidiary, which will be able to produce both drug substance and drug product.

(Image: Getty/Manjural)

The journey to an approved Ebola vaccine

By Ben Hargreaves

Europe approved the first vaccine for the Ebola virus, but the path to reach this point has taken many years and required a global effort.

(Image: Getty/LightFieldStudios)

Amgen joins neuroscience exodus

By Ben Hargreaves

In third quarter financials, Amgen announces that it will end its R&D efforts in neuroscience to focus on diseases with a ‘large public health impact.

Follow us

Products

View more

Webinars